{"id":"W4389621900","doi":"10.1681/asn.0000000000000274","title":"The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Medical Research Council; Genentech; Sangamo Therapeutics; Sanofi; Renal Pathology Society; Canadian Institute for Theoretical Astrophysics; Celltrion; Wellcome Trust; Alexion Pharmaceuticals; Amgen; Vifor Pharma; Pfizer; Omeros Corporation; Health Service Executive; Fresenius Medical Care North America; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"ANCA-Associated Vasculitis; Medicine; Internal medicine; Clinical Practice; Vasculitis; Clinical trial; Physical therapy; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":{"n_in":0,"stratum":"fund_new","weight":1678.9,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Development and validation of a clinical kidney risk prediction score in ANCA-associated vasculitis; a clinical prognostic tool, not a study of research practice."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"The study develops and validates a clinical risk score for ANCA-associated vasculitis."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Clinical prognostic score for ANCA-associated kidney disease; object is disease risk, not trial methodology."}}}